ClinicalTrials HQ

A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C

A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C

Active, not recruiting · NCT05975021 · Registry updated 2025-08-20
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage CInfarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, Shock, Cardiogenic, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorderActive, not recruitingPhase 1 / Phase 22025-08-20NCT05975021

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Windtree Therapeutics2

15 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
4 Wojskowy Szpital Kliniczny z Polikliniką SP ZOZWroclawPoland1
Asst Degli Spedali Civili Di BresciaBresciaItaly22
Azienda Ospedaliera Santi Antonio e Biagio e Cesare ArrigoAlessandriaItaly2
Hospital Privado de RosarioRosarioArgentina1
Instituto Cardiovascular de RosarioRosarioArgentina1
IRCCS San Raffaele Scientific InstituteMilanItaly13
Kaplan Medical CenterRehovotIsrael10
Oregon Health and Sciences UniversityPortlandUnited States1
Sanatorio De la Trinidad PalermoCapital FederalArgentina1
Sanatorio GüemesCapital FederalArgentina1
Tufts Medical CenterBostonUnited States238
University of Turin, Città della Salute e della ScienzaTurinItaly1
Uniwersytecki Szpital Kliniczny w BiałymstokuBialystokPoland7
Uniwersytecki Szpital Kliniczny w OpoluOpolePoland9
Uniwersytecki Szpital Kliniczny, Instytut Chorob SercaWroclawPoland1